Bipartisan Senate Finance Framework Takes ‘Measured’ Aim At PBMs

Framework from Sens. Wyden and Crapo, looks like it would change, but not eliminate, the rebate system and gets an initial thumbs up from both the brand and generic drug lobbies.

Congress and middlemen
Legislation would not cut out the middleman. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images

More from Pricing Debate

More from Market Access